Patents by Inventor Christopher A. Hurley

Christopher A. Hurley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Azadecalin Glucocorticoid receptor modulators
    Patent number: 7678813
    Abstract: The present invention provides a novel class of azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Grant
    Filed: January 10, 2005
    Date of Patent: March 16, 2010
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Robin D. Clark, Nicholas C. Ray, Paul Blaney, Christopher Hurley, Hazel Hunt, David Clark, Karen Williams
  • Materials for the delivery of biologically-active material to cells
    Patent number: 7598421
    Abstract: The invention provides a lipid of general formula (I) or (II): wherein X1, X2 and R1 to R5 are as defined herein. Such lipids are used to form complexes with a biologically-active material such as a nucleic acid, peptide or small molecule for delivering the biologically-active material to cells. The complexes may incorporate an integrin-binding peptide and, when the biologically-active material is DNA, thereby constitute a LID complex.
    Type: Grant
    Filed: November 8, 2004
    Date of Patent: October 6, 2009
    Assignee: UCL Biomedica PLC
    Inventors: Helen C. Hailes, Alethea B. Tabor, John B. Wong, Michael Pilkington-Miksa, Stephen L. Hart, Christopher A. Hurley
  • Fused Ring Azadecalin Glucocorticoid Receptor Modulators
    Publication number: 20070281928
    Abstract: The present invention provides a novel class of fused ring azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: March 9, 2005
    Publication date: December 6, 2007
    Inventors: Robin Clark, Nicholas Ray, Paul Blaney, Christopher Hurley, Karen Williams
  • Azadecalin Glucocorticoid Receptor Modulators
    Publication number: 20070203179
    Abstract: The present invention provides a novel class of azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: January 10, 2005
    Publication date: August 30, 2007
    Applicant: Corcept Therapeutics, Inc.
    Inventors: Robin Clark, Nicholas Ray, Paul Blaney, Christopher Hurley, Hazel Hunt, David Clark, Karen Williams
  • Materials for the delivery of biologically-active material to cells
    Publication number: 20050245446
    Abstract: The invention provides a lipid of general formula (I) or (II): wherein X1, X2 and R1 to R5 are as defined herein. Such lipids are used to form complexes with a biologically-active material such as a nucleic acid, peptide or small molecule for delivering the biologically-active material to cells. The complexes may incorporate an integrin-binding peptide and, when the biologically-active material is DNA, thereby constitute a LID complex.
    Type: Application
    Filed: November 8, 2004
    Publication date: November 3, 2005
    Inventors: Helen Hailes, Alethea Tabor, John Wong, Michael Pilkington-Miksa, Stephen Hart, Christopher Hurley